These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15974158)

  • 1. The effects of race and criminal justice involvement on access to atypical antipsychotic medications among persons with schizophrenia.
    Van Dorn RA; Swanson JW; Swartz MS; Elbogen EB
    Ment Health Serv Res; 2005 Jun; 7(2):123-34. PubMed ID: 15974158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term antipsychotic polypharmacy in the VA health system: patient characteristics and treatment patterns.
    Kreyenbuhl JA; Valenstein M; McCarthy JF; Ganoczy D; Blow FC
    Psychiatr Serv; 2007 Apr; 58(4):489-95. PubMed ID: 17412850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial disparities in antipsychotic prescription patterns for patients with schizophrenia.
    Kuno E; Rothbard AB
    Am J Psychiatry; 2002 Apr; 159(4):567-72. PubMed ID: 11925294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and use patterns of patients taking first-generation depot antipsychotics or oral antipsychotics for schizophrenia.
    Shi L; Ascher-Svanum H; Zhu B; Faries D; Montgomery W; Marder SR
    Psychiatr Serv; 2007 Apr; 58(4):482-8. PubMed ID: 17412849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential disparities in the management of schizophrenia in the United States.
    Rost K; Hsieh YP; Xu S; Menachemi N; Young AS
    Psychiatr Serv; 2011 Jun; 62(6):613-8. PubMed ID: 21632729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in use of second-generation antipsychotic medication by race among adult psychiatric patients.
    Herbeck DM; West JC; Ruditis I; Duffy FF; Fitek DJ; Bell CC; Snowden LR
    Psychiatr Serv; 2004 Jun; 55(6):677-84. PubMed ID: 15175466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Race and long-acting antipsychotic prescription at a community mental health center: a retrospective chart review.
    Aggarwal NK; Rosenheck RA; Woods SW; Sernyak MJ
    J Clin Psychiatry; 2012 Apr; 73(4):513-7. PubMed ID: 22579151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial differences in antipsychotic use: Claims database analysis of Medicaid-insured patients with schizophrenia.
    Lawson W; Johnston S; Karson C; Offord S; Docherty J; Eramo A; Kamat S; Blanchette CM; Carson W; Nasrallah HA
    Ann Clin Psychiatry; 2015 Nov; 27(4):242-52. PubMed ID: 26554365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of clinical symptoms and substance use in schizophrenia patients on conventional versus atypical antipsychotics.
    Scheller-Gilkey G; Woolwine BJ; Cooper I; Gay O; Moynes KA; Miller AH
    Am J Drug Alcohol Abuse; 2003 Aug; 29(3):553-66. PubMed ID: 14510040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial Disparities in Clozapine Prescription Patterns Among Patients With Schizophrenia.
    Barry S; Jarskog LF; Xia K; Torpunuri RS; Wu X; Zeng X
    Psychiatr Serv; 2024 Aug; 75(8):733-739. PubMed ID: 38500451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial disparity in the use of atypical antipsychotic medications among veterans.
    Copeland LA; Zeber JE; Valenstein M; Blow FC
    Am J Psychiatry; 2003 Oct; 160(10):1817-22. PubMed ID: 14514496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Who receives long-acting antipsychotic medications?
    Glazer WM
    Psychiatr Serv; 2007 Apr; 58(4):437. PubMed ID: 17412839
    [No Abstract]   [Full Text] [Related]  

  • 13. Ethnic differences in use of antipsychotic medication among Texas medicaid clients with schizophrenia.
    Opolka JL; Rascati KL; Brown CM; Barner JC; Johnsrud MT; Gibson PJ
    J Clin Psychiatry; 2003 Jun; 64(6):635-9. PubMed ID: 12823076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia.
    Ascher-Svanum H; Nyhuis AW; Faries DE; Ball DE; Kinon BJ
    BMC Psychiatry; 2010 Jan; 10():11. PubMed ID: 20109170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excessive antipsychotic dosing in 2 U.S. State hospitals.
    Diaz FJ; De Leon J
    J Clin Psychiatry; 2002 Nov; 63(11):998-1003. PubMed ID: 12444813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethnicity and prescription patterns for haloperidol, risperidone, and olanzapine.
    Opolka JL; Rascati KL; Brown CM; Gibson PJ
    Psychiatr Serv; 2004 Feb; 55(2):151-6. PubMed ID: 14762239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to employment for people with schizophrenia.
    Rosenheck R; Leslie D; Keefe R; McEvoy J; Swartz M; Perkins D; Stroup S; Hsiao JK; Lieberman J;
    Am J Psychiatry; 2006 Mar; 163(3):411-7. PubMed ID: 16513861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial differences in the use of adjunctive psychotropic medications for patients with schizophrenia.
    Mallinger JB; Lamberti SJ
    J Ment Health Policy Econ; 2007 Mar; 10(1):15-22. PubMed ID: 17417044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic prescribing patterns in the Texas prison system.
    Baillargeon J; Contreras SA
    J Am Acad Psychiatry Law; 2001; 29(1):48-53. PubMed ID: 11302386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Program-level predictors of antipsychotic medication adherence among parolees.
    Farabee D; Shen H; Sanchez S
    Int J Offender Ther Comp Criminol; 2004 Oct; 48(5):561-71. PubMed ID: 15358931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.